Shire adding in-house Cinryze production after shortage, but continues to shed plants
admin 30th October 2017 Uncategorised 0Shire intends to take some manufacturing of its rare disease drug Cinryze in house after problems with a contractor led to a shortage of the drug. The move comes even as Shire has targeted three more plants for elimination in its efforts to pare down its production network after picking up a bunch of plants in its buyout of Baxalta.
More: Shire adding in-house Cinryze production after shortage, but continues to shed plants
Source: fierce